Skip to the page

Data / Form D filings / Mirador Therapeutics, Inc.

Mirador Therapeutics, Inc.: Form D filings

Mirador Therapeutics, Inc., a health care company in San Diego, CA, filed 2 Form D notices with the SEC in 2024. The latest, on April 3, 2024, reports $333 million sold of a $333 million offering to 31 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3115 Merryfield Row, Suite 210, San Diego, CA, 92121
Phone
(858) 523-5400
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2017193

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 3, 2024New notice$332,999,976$332,999,97631Feb 15, 2024sec.gov
Apr 3, 2024New notice$80,000,000$80,000,0003Dec 14, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Paul K. BernsDirector
Timothy K. AndrewsExecutive Officer
David K. Bonita, M.D.Director
Mark C. McKennaExecutive Officer, Director
Scott K. GlennDirector
Kristina K. BurowDirector
Vika K. BroughExecutive Officer
Joseph K. PapaDirector

Other health care companies in California that filed recently

Every Form D from the week of Apr 1, 2024 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Mirador Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.